Mohammed Abdul Khader

Employment

Employment history is unavailable.

Education

• Bhaskar Pharmacy College Doctor of Pharmacy
  2016 - Present

Projects & Funding

Projects & funding information is unavailable.

Publications (12)

• 693-P: Significant Changes in Dietary Behaviour, Glycemic Control, and Weight after Participation in Personalized Glycemic Response–Based Diabefly Program
  Diabetes 2022 DOI: 10.2337/db22-693-p
  +Save
• 703-P: Significant Weight Reduction and Improvement in Glycemic Control among People with T2D after Participation in Diabefly Digital Therapeutics Program
  Diabetes 2022 DOI: 10.2337/db22-703-p
  +Save
• Participation in Diabefly® digital therapeutics program leads to significant improvement in glycemic control and reduction in weight and BMI among people with T2D
  Endocrine Abstracts 2022 DOI: 10.1530/endoabs.81.p315
  +Save
• Personalized glycemic response based Diabefly-Pro® digital therapeutics improves dietary patterns, glycemic control and reduces postprandial hyperglycemia in real-world settings
  Endocrine Abstracts 2022 DOI: 10.1530/endoabs.81.p326
  +Save
• Improved glycemic control among people with type 2 diabetes with a digital therapeutics approach in collaboration with clinicians
  Indian Journal of Endocrinology and Metabolism 2022
  +Save
• Post-COVID-19-associated decline in long-term male fertility and embryo quality during assisted reproductive technology
  QJM: An International Journal of Medicine 2021 DOI: 10.1093/qjmed/hcab019
  +Save
• Response to letter to editor
  QJM: An International Journal of Medicine 2021 DOI: 10.1093/qjmed/hcab039
  +Save
• A cross sectional study reveals severe disruption in glycemic control in people with diabetes during and after lockdown in India
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020 DOI: 10.1016/j.dsx.2020.08.011
  +Save
• A case of dapsone hypersensitivity syndrome in an Indian leprosy patient: Retrospective screening reveals the genetic connection with HLA‐B *13:01
  Dermatologic Therapy 2020 DOI: 10.1111/dth.13825
  +Save
• A REVIEW ON THE ANTIPARASITIC DRUG IVERMECTIN FOR VARIOUS VIRAL INFECTIONS AND POSSIBILITIES OF USING IT FOR NOVEL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2: NEW HOPE TO TREAT CORONAVIRUS DISEASE-2019
  Asian Journal of Pharmaceutical and Clinical Research 2020 DOI: 10.22159/ajpcr.2020.v13i8.38357
  +Save